3 0 2 VOLUME 13 | NUMBER 3 | MARCH 2010 nature neurOSCIenCe a r t I C l e S A central question in neuronal signal transduction, and indeed in cell biology in general, is how extracellular factors elicit a complex set of signaling events to achieve specific cellular functions. Given that many intracellular signaling pathways are shared by multiple extracellular factors, how could two factors that trigger the same signaling events bring about completely different functions in the same cells? For example, although both epidermal growth factor (EGF) and nerve growth factor (NGF) activate mitogen-associated protein kinase (MAPK) in PC12 cells, EGF triggers cell division and NGF induces neurite outgrowth 1,2 . In hippocampus, both BDNF and neuregulin induce the activation of MAPK, phosphotidylinositol-3 kinase and phospholipase C-γ (PLC-γ) pathways 3,4 . However, BDNF facilitates long-term potentiation (LTP), whereas neuregulin suppresses it [5] [6] [7] [8] [9] . An attractive idea is that two factors may activate the same signaling pathways with different kinetics. Thus, EGF induces a transient activation of MAPK in PC12 cells that results in proliferation, whereas NGF induces a more sustained activation of MAPK that results in differentiation 10 . Can a single extracellular factor elicit different cellular functions by activating similar signaling molecules with different kinetics?
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A central question in neuronal signal transduction, and indeed in cell biology in general, is how extracellular factors elicit a complex set of signaling events to achieve specific cellular functions. Given that many intracellular signaling pathways are shared by multiple extracellular factors, how could two factors that trigger the same signaling events bring about completely different functions in the same cells? For example, although both epidermal growth factor (EGF) and nerve growth factor (NGF) activate mitogen-associated protein kinase (MAPK) in PC12 cells, EGF triggers cell division and NGF induces neurite outgrowth 1, 2 . In hippocampus, both BDNF and neuregulin induce the activation of MAPK, phosphotidylinositol-3 kinase and phospholipase C-γ (PLC-γ) pathways 3, 4 . However, BDNF facilitates long-term potentiation (LTP), whereas neuregulin suppresses it [5] [6] [7] [8] [9] . An attractive idea is that two factors may activate the same signaling pathways with different kinetics. Thus, EGF induces a transient activation of MAPK in PC12 cells that results in proliferation, whereas NGF induces a more sustained activation of MAPK that results in differentiation 10 . Can a single extracellular factor elicit different cellular functions by activating similar signaling molecules with different kinetics?
The kinetics of signaling may be influenced not only by distinct cell surface receptors but also by the method by which their cognate ligands are secreted or delivered. A receptor may be acutely activated on an immediate increase in ligand concentration as a result of its regulated secretion. This process is mimicked by most, if not all, pharmacological studies in which a ligand or drug is applied directly to cells grown in culture. In many cellular processes in vivo, however, cells encounter a gradual increase in the concentration of extracellular factors. A constitutively secreted factor needs to accumulate over time to reach a threshold set by the affinity of the receptor. Moreover, when a ligand is secreted from a distant source, the responding cells may experience a gradual increase in the concentration of the ligand. So far, no study has addressed the question of whether acute and gradual increases in extracellular factors would induce the same or different set of signaling events and cellular functions.
As one of the most extensively studied extracellular factors, BDNF is an ideal model to address this question. BDNF is secreted through both constitutive and regulated secretory pathways [11] [12] [13] [14] [15] [16] . The biological function of mature BDNF is mediated by the TrkB receptor tyrosine kinase, which activates the downstream MAPK, phosphotidylinositol-3 kinase and PLC-γ pathways 4 . Often very different effects have been observed in the same cells when BDNF is applied pharmacologically. For example, in hippocampal slices, bath application of BDNF induces a long-lasting enhancement of basal synaptic transmission 9 . In contrast, many studies have shown that perfusion of BDNF facilitates LTP, but not basal synaptic transmission 6, 8, 17, 18 , in the same CA1 synapses. One explanation for the discrepancy is that acute potentiation of synaptic efficacy requires a fast delivery of BDNF to hippocampal slices 19, 20 . Can fast delivery of BDNF elicit signaling mechanisms different from that of slow delivery?
In an attempt to mimic a gradual increase of extracellular BDNF concentration ([BDNF]) in vivo, we devised a method of BDNF delivery that allows a tenfold increase in [BDNF] in neuronal cultures every 30 min. We found that a gradual increase in [BDNF] elicited markedly different kinetics of TrkB activation and its downstream signaling events as compared with conventional, acute increase in [BDNF] . We found that the two modes of BDNF delivery also elicited a r t I C l e S very different morphological changes in cultured hippocampal neurons. Furthermore, fast and slow increases in [BDNF] in hippocampal slices had differential effects on gene expression and synaptic modulation. Thus, the mode of BDNF delivery or other bioactive agents may influence their signaling and functions. These results may also have general implications for both cell biology and drug therapy.
RESULTS

Differential signaling kinetics by acute and gradual modes
To examine whether the kinetics of TrkB activation could be regulated by the temporal rate of BDNF stimulation, we designed two different modes of BDNF delivery to cultured hippocampal neurons ( Fig. 1a and Online Methods) and measured TrkB phosphorylation at various time points (Fig. 1b) . One was an acute application of BDNF, which resulted in an immediate increase in BDNF concentration to 1 nM (acute mode, 25 ng ml −1 ). The other was a gradual increase in BDNF concentration (gradual mode) in which we added BDNF to cultures to increase its concentration tenfold every 30 min, from an initial 0.0001 nM (10 −4 nM, 2.5 pg ml −1 ) to a final concentration of 1 nM (25 ng ml −1 ). The acute application of BDNF triggered a robust, but transient, increase in TrkB phosphorylation; the level of phosphorTrkB (pTrkB) reached its peak at about 15 min, but declined rapidly and returned to baseline 2 h after BDNF application (Fig. 1b) . In contrast, a gradual increase in BDNF concentration resulted in a longlasting activation of TrkB (Fig. 1b) . TrkB was activated at a relatively lower level when BDNF concentration was below 1 nM. When BDNF concentration reached 1 nM, pTrkB slowly increased and reached a maximum level within 1 h, and the level persisted for up to 8 h with no sign of decline.
A previous study reported that acute application of BDNF results in a rapid degradation of TrkB protein in cultured cerebellar granule neurons 21 . To determine whether transient and sustained activation of TrkB were the results of different kinetics of TrkB synthesis and/or degradation, we measured total TrkB protein levels by western blot.
The levels of full-length TrkB remained constant at various time points after acute and gradual BDNF deliveries (Fig. 1b) . We performed biotinylation assays to measure cell surface TrkB at different time points (Fig. 1c) . A 15-s acute BDNF application was included as a positive control, as this treatment is known to facilitate insertion of TrkB into cell surface 22 . Acute BDNF application reduced surface TrkB expression, possibly as a result of BDNF-induced endocytosis of TrkB. In contrast, gradual BDNF application resulted in a transient and slight decrease in surface TrkB expression, which recovered after 4 h. These results are consistent with previous findings in cultured cells 22, 23 and suggest that the transient pattern of TrkB phosphorylation induced by acute BDNF application is caused possibly by reduction in TrkB receptor surface expression, rather than by downregulation of TrkB protein.
A previous study found that TrkB phosphorylation is BDNF dose dependent and TrkB is maximally phosphorylated in 5 min by 1 nM BDNF 24 . The kinetics of signaling induced by acute and gradual BDNF applications at 0.1 nM are very similar to those at 1 nM (compare Supplementary Fig. 1 and Fig. 1) . Thus, it is not the final concentration but the mode of BDNF delivery that is important for the kinetics of TrkB signaling. To confirm that the kinetics, rather than the magnitude of the signal, accounts for the difference between gradual and acute modes, we used BDNF at a final concentration of 1 nM for both acute and gradual treatments.
We next examined whether transient and sustained TrkB activation triggers different temporal patterns of signal transduction. Acute and gradual BDNF application elicited very different patterns of Erk phosphorylation (Fig. 1b) . Acute administration of BDNF induced a marked increase in Erk phosphorylation that peaked around 15 min, followed by a rapid decrease in the next 60 min. A stepwise increase in [BDNF] induced a slow and sustained increase in Erk phosphorylation that persisted for 8 h. After BDNF concentration reached 1 nM, pErk reached a maximum level at 1 h and then fell slowly over a long period of time. These data suggest that transient and sustained activation of 
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TrkB, induced by acute and gradual modes of BDNF delivery, respectively, may lead to different kinetics of MAPK activation. Previous studies have found that small GTPases Ras and Rap1 differentially control the kinetics of MAPK activation; Ras-dependent signaling to Erk is transient, whereas Rap1-dependent signaling to Erk is sustained 25 . The level of activated Ras increased and then decreased quickly under both experiment conditions, although the change induced by gradual application came slightly slower than that induced by acute application ( Supplementary Fig. 2 ). However, Rap1 was activated transiently in acute mode, whereas it showed sustained activation for at least 8 h in gradual mode ( Supplementary Fig. 2 ). These results support the notion that acute application of BDNF induces a transient Ras-MAPK signaling, whereas gradual application of BDNF triggers a sustained Rap1-MAPK signaling.
We also examined GSK-3β and PLC-γ1 signaling, the other two important signaling pathways that are downstream of TrkB. An acute increase in [BDNF] elicited a transient increase in the phosphorylation levels of both GSK-3β and PLC-γ1, whereas gradual application of BDNF led to a sustained increase (Supplementary Fig. 3 ). These results suggest that the primary difference between the two modes of BDNF application is at the level of TrkB receptor, leading to differences in the kinetics of all three signaling pathways.
We carried out two control experiments. First, applications of saline in a similar manner (five times, every 30 min, saline group) did not induce TrkB or MAPK activation, suggesting that sustained TrkB activation is not a result of the mechanic stress of repeated applications (Fig. 1) . Second, deletion of p75 NTR , another BDNF receptor, had little effect on the kinetics of TrkB and MAPK activation ( Supplementary Fig. 4 ), suggesting that it is not involved in the differential signaling.
Transcription induced by gradual, but not acute, mode
In the next series of experiments, we tested whether the two modes of BDNF stimulation have differential effects on gene expression. The transcription factor CREB is a critical mediator for BDNFinduced gene expression and is crucial for the long-lasting synaptic effects of BDNF 26 . Acute application of BDNF induced a rapid, but transient, increase in pCREB (Supplementary Fig. 5 ). On gradual BDNF stimulation, however, the increase in pCREB lasted as long as 8 h. Immunocytochemistry revealed intense staining of pCREB in the nucleus of hippocampal neurons. Quantification of the percentage of neurons with nuclear pCREB again indicated that there was a transient CREB activation in response to acute BDNF application but a long-lasting activation with gradual increase in [BDNF] (Supplementary Fig. 5 ).
The MAPK-CREB signaling pathway is known to be involved in the transcription of the immediate early genes Arc and Homer1 (refs. 27,28) . Acute application of BDNF has been shown to rapidly increase Arc and Homer1 mRNA levels, particularly in the synaptodendritic compartment 28, 29 . Acute application of BDNF elicited little increase in Arc or Homer1 proteins in hippocampal cultures under our experimental conditions (Fig. 2) . Arc and Homer1 protein levels slightly increased over a period of 60 min after BDNF treatment and returned to the basal level in 2 h. In contrast, under gradual mode, the levels of Arc and Homer1 increased quickly as [BDNF] reached 1 nM. The elevation persisted up to 8 h after 1 nM BDNF stimulation (Fig. 2b) . Our results suggest that sustained TrkB activation has different consequences for protein expression as compared with transient TrkB activation.
Reversal of acute and gradual TrkB signaling by K252a
To investigate whether a sustained TrkB signaling could be converted to a transient signal, we applied K252a after TrkB activity had reached its peak in gradual mode (2 h after stepwise BDNF application) and monitored the subsequent signaling patterns in cultured hippocampal neurons. Sustained TrkB activation was largely reversed by K252a, as were sustained expression levels of Homer1 and Arc (Supplementary Fig. 6 ).
We performed similar experiments using U0126, a MEK inhibitor. As expected, U0126 applied 2 h after gradual BDNF application reversed sustained MAPK phosphorylation and sustained expression of Homer1 and Arc (Supplementary Fig. 7 ). Because MAPK is downstream of TrkB, it is not surprising that U0126 did not affect sustained TrkB activation (Supplementary Fig. 7 ). To our surprise, delayed K252a application had little effect on sustained MAPK activation Figure 9 . Data are presented as mean ± s.e.m., *P < 0.05, **P < 0.01. ( Supplementary Fig. 6 ). These results imply that TrkB may trigger some special downstream signaling events once it is activated in the sustained mode, leading to long-term, irreversible biological changes. 
Differential effects on morphological plasticity
Previous studies have shown that BDNF is important for dendritic growth and the morphological specializations of dendrites 30, 31 . We therefore asked whether the two modes of BDNF stimulation could elicit differential effects on neurite growth in developing neurons. We treated young hippocampal neurons (3-d-old culture) with BDNF either acutely or gradually and grew the cultures for an additional 3 d. We fixed cultures and immunostained neurons with antibody to MAP2 for morphometric analysis (Fig. 3) . Neurite growth was quantified by three parameters: total neurite length, number of first-order (primary) neurites and number of branch points ( Table 1 ). The total neurite length was 221.1 ± 12.5, 368.7 ± 17.0 and 418.1 ± 19.2 µm for control, gradual and acute modes, respectively. Compared with gradual stimulation, acute application of BDNF had a more pronounced effect on the number of primary dendrites; the number of first-order neurites was 2.3-fold higher in acute mode, but only 1.5-fold higher in gradual mode, relative to control (significantly different between acute and gradual modes, P < 0.01, ANOVA). Notably, the number of branch points in gradual experiments averaged 4.13 ± 0.22 per cell, as compared with 1.65 ± 0.14 per cell in control neurons. However, the number of branch points from acute experiments averaged 2.38 ± 0.17 per cell, only slightly more than control (significantly different between acute and gradual experiments; P < 0.01, ANOVA). Preincubation with 100 nM K252a completely eliminated the ability of both acute and gradual BDNF to elicit neurite outgrowth (Fig. 3) . Collectively, our results suggest that neurite branching seems to be sensitive to gradual BDNF stimulation in early development, whereas acute BDNF stimulation promotes neurite elongation. BDNF also regulates dendritic spine growth late in development 30, 32 . To determine whether spine growth is differentially regulated by two the different modes of BDNF stimulation, we used older hippocampal neurons (21 d in culture), which exhibited many spines with well-defined heads (Fig. 4a) . The neurons had much more prominent dendritic spines 24 h after acute BDNF stimulation, the majority of which were mushroom shaped, with spine heads being larger than those of control neurons. Gradual BDNF stimulation for the same period (24 h) had different effects on dendritic spine growth. More filopodia-like outgrowth was observed and the spines were longer. Quantitative analysis indicated that spine density doubled on acute BDNF stimulation (control, 2.39 ± 0.15; acute, 4.59 ± 0.18; P < 0.01, ANOVA), whereas the density of filopodia-like protrusions was only modestly increased (control, 0.58 ± 0.05; acute, 0.77 ± 0.05) (Fig. 4b) . 
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The most notable effect of gradual BDNF stimulation was to significantly increase the density of filopodia-like protrusion; spine density increased only 50% (3.60 ± 0.15, P < 0.01, ANOVA), whereas filopodia density almost doubled (1.04 ± 0.07, P < 0.01, ANOVA) compared with control. We next compared how acute and gradual modes affect the shape or morphology of spines. The mean length of spines was significantly increased in neurons treated with the gradual mode of BDNF delivery (P < 0.01; Fig. 4c) . However, the mean width of spine heads significantly increased in neurons treated with acute mode of BDNF delivery (P < 0.01; Fig. 4d ). Acute BDNF treatment also caused a modest increase in spine length as compared with control, but this effect could be attributed to the increase in head diameter. In addition, pretreatment with K252a markedly reduced BDNF-induced dendritic spine growth and morphology changes (K252a and acute, 2.65 ± 0.29 spine density, 0.67 ± 0.14 filopodia-like protrusion density; K252a and gradual, 2.10 ± 0.49 spine density, 0.51 ± 0.15 filopodia-like protrusion density; Fig. 4) . These results suggest that, in mature neurons, a gradual increase in [BDNF] promotes the outgrowth of filopodia-like protrusions and the length of spines, whereas an acute elevation of [BDNF] results in more spines with larger heads.
Differential synaptic effects in hippocampal slices
As a first step toward exploring the different kinetics of BDNF signaling in vivo, we attempted to examine the effects of acute and gradual BDNF stimulation in hippocampal slices. Although it is generally accepted that certain levels of BDNF are necessary for LTP 5, 6 , disagreement exists as to whether BDNF itself could enhance basal synaptic transmission in the Schaffer collateral pathway in hippocampal slices 6, 8, 17, 18 . It has been suggested that a high perfusion rate (240 ml h −1 ) allows BDNF to penetrate into the slices, leading to synaptic potentiation 19 . However, this argument may not explain why perfusion of BDNF at a much lower rate (25 ml h −1 ) facilitates LTP 8 . To determine the kinetics of BDNF signaling in hippocampal slices, we dissected CA1 areas at different time points after BDNF (8 nM, 200 ng ml −1 ) application in slices from 8-week-old mice and examined the levels of TrkB and MAPK activation by western blot. Fast (240 ml h −1 ) and slow (25 ml h −1 ) rates of BDNF perfusion induced transient and sustained activation of TrkB and MAPK signaling, respectively (Fig. 5a-c) . We also examined the time course of the expression of the immediate early genes Arc and Homer1 using western blot. Arc and Homer1 levels in CA1 region were increased only in slices perfused with BDNF at the slow rate ( Fig. 5d-f) .
Furthermore, in slices derived from adult (8 week old) mice, basal synaptic transmission in CA1 was not affected by slow perfusion (25 ml h −1 ) of BDNF (101 ± 1% at 175-180 min; Fig. 6a ). In contrast, perfusion of BDNF at a high rate (240 ml h −1 ) markedly enhanced synaptic efficacy (153 ± 5% at 175-180 min; Fig. 6a ). Consistent with previous findings 9 , a brief (30 min) high-speed perfusion of BDNF could induce synaptic potentiation, which was BDNF dependent (Supplementary Fig. 8 ) and could last for at least 3 h (149 ± 8% at 175-180 min; Fig. 6b) .
To examine the effects of slow BDNF perfusion, we used slices derived from neonatal hippocampus (2 week old), where endogenous BDNF is low 8 . Neither a high nor a low rate of BDNF perfusion could change basal synaptic transmission at this age (Fig. 6c,d) . In contrast, slow perfusion of BDNF facilitated LTP induced by a relatively weak theta-burst stimulation (three bursts of four pulses at 100 Hz, or 3× TBS), which otherwise induced only small potentiation (150 ± 4% for BDNF, 130 ± 2% for bovine serum albumin (BSA), at 115-120 min, P < 0.001; Fig. 6e) . Moreover, application of 3× TBS induced a synaptic fatigue (defined as last excitatory postsynaptic potential (EPSP) of third burst/first EPSP of first burst, 38 ± 6%; Fig. 6f ) at Schaffer collateral-CA1 synapses, and slow perfusion of BDNF for 2 h significantly attenuated synaptic fatigue (71 ± 8%, P < 0.01). Pretreatment with K252a completely prevented the effects of slow BDNF perfusion on LTP (127 ± 6%) and synaptic fatigue (42 ± 5%) in neonatal hippocampal slice (Fig. 6e,f) . However, a high rate of BDNF perfusion had no effect on either TBS-induced LTP (131 ± 4% for BDNF, 128 ± 5% for BSA, at 115-120 min; Fig. 6g ) or synaptic fatigue (45 ± 5% for BDNF, 47 ± 7% for BSA; Fig. 6h) . Thus, in addition to eliciting differential kinetics of signaling, slow BDNF delivery facilitates LTP in developing hippocampus, whereas a fast increase in [BDNF] enhances basal synaptic transmission in adult hippocampus.
A recent study found that BDNF causes depolarization of postsynaptic neuron and regulates NMDA receptors 33 . We therefore performed whole-cell recording experiments on hippocampal slices. BDNF regulation of synapses depended on developmental stages. In 2-week-old hippocampal slices, NMDA receptor (NMDAR)-mediated currents were significantly increased after fast, but not slow, perfusion of BDNF ((P = 0.009; Fig. 7a-c) . At this stage, AMPA receptor (AMPAR) currents were quite small and variable, and silent (NMDAR only) synapses were quite prominent. It was therefore difficult to measure The experiments were performed as in a. Representative western blots (d) and quantification of data (e,f) (n = 3 repetitions of pooled slices). The same experiment was repeated using entirely independent samples and the same results were obtained. Data are presented as mean ± s.e.m., *P < 0.05, **P < 0.01, ANOVA. Full-length blots are presented in Supplementary Figure 9 .
a r t I C l e S the AMPAR/NMDAR current ratio accurately (data not shown). In 8-week-old hippocampal slices, neither fast nor slow application of BDNF altered NMDAR-mediated excitatory postsynaptic currents (EPSCs; Fig. 7d-f) . In contrast, fast, but not slow, application of BDNF increased the AMPAR/NMDAR current ratio (Fig. 7g) , possibly as a result of a significant increase (P < 0.05) in AMPARmediated synaptic currents, as previously reported 9 .
DISCUSSION
Controlling the kinetics of signal transduction may be an important mechanism for ensuring the functional specificity of extracellular factors. Rigorous studies have suggested that specific cellular functions of growth factor receptors can be achieved by activation of identical signaling events with distinct kinetics 1, 34 . It is unclear, however, whether the same factor can elicit distinct functions on the same cells and, if so, what the underlying mechanisms may be. We found that BDNF, when delivered to the same hippocampal neurons in acute or gradual mode, could induce transient and sustained TrkB activation, respectively, which in turn led to distinct downstream signaling events, different effects on dendritic morphology and spine growth. In hippocampal slices, fast delivery of BDNF (acute mode) enhanced basal synaptic transmission, whereas slow delivery (gradual mode) a r t I C l e S facilitated LTP. The difference in TrkB membrane re-insertion provides explains why gradual and acute applications of BDNF elicit very different kinetics of TrkB and MAPK activations. These results reveal a new dimension to the study of neurotrophin signaling and function and challenged the relevance of a commonly used approach in signal transduction research.
Because of a lack of sensitive tools in measuring the sites and modes of endogenous BDNF secretion, we can not directly demonstrate that BDNF is delivered in two different modes in vivo and that these two modes elicit different function. However, similar to acute and gradual application of BDNF to cultured neurons, fast and slow rates of BDNF perfusion induced transient and sustained activation of TrkB and MAPK signaling, respectively (Fig. 5a-c) . Furthermore, Arc and Homer1 levels in CA1 region were only increased in slices perfused with BDNF at slow, but not fast, rates (Fig. 5d-f) . Thus, we reasoned that slow and fast perfusion rates may result in slow and fast increases in [BDNF] , mimicking the acute and gradual modes, respectively. BDNF is secreted through both constitutive and regulated secretory pathways [11] [12] [13] [14] [15] [16] . It is conceivable that endogenous [BDNF] is increased gradually when the factor is secreted constitutively or from a distant source. On the other hand, a rapid increase of [BDNF] could occur locally as a result of regulated secretion triggered by intense neuronal firing. Furthermore, neuronal firing in vivo might alter the signaling differences between acute and gradual delivery. The results of our preliminary experiments suggest that continuous chemical depolarization with high K + sustains acute BDNF-induced TrkB and MAPK activations and minimizes the differences between acute and stepwise BDNF administration (data not shown). Future work is necessary to establish the two modes of BDNF actions in vivo.
Transient and sustained TrkB activations resulting from different modes of BDNF delivery may help to resolve a long-standing debate in the field of BDNF and synaptic plasticity: whether BDNF can elicit acute potentiation of synaptic efficacy in hippocampal slices. Analogous to the acute application of BDNF to neuronal cultures 35, 36 , fast perfusion of exogenous BDNF to hippocampal slices has been found to induce a rapid and long-lasting potentiation of synaptic efficacy (BDNF-LTP) at CA1 synapses 9 . This result was quite provocative, as most exogenous factors modulate tetanus-induced LTP without altering basal transmission. Nevertheless, subsequent attempts by a number of laboratories failed to replicate this finding 6, 8, 17, 18 . Notably, most of these studies used a relatively slow rate of BDNF perfusion. A previous study argued that an important factor in BDNF-induced synaptic potentiation is fast perfusion, which allows BDNF to penetrate into the slices 19, 20 . However, under the conditions that failed to observe acute synaptic potentiation, BDNF was found to suppress GABA-mediated inhibitory synaptic currents 17, 18 and facilitate synaptic responses to high-frequency stimulation 8 , suggesting that the molecule successfully entered the slices. Building on our findings that acute and gradual increase in [BDNF] may lead to profoundly different biological effects in cultured hippocampal neurons, we revisited the issue. Our data suggest that fast perfusion, even transiently, does induce synaptic potentiation (Fig. 6a,b) , but this is not because of its ability to penetrate the slices. In fact, in 30 min, both fast and slow perfusion induced similar magnitude of TrkB activation (Fig. 5a) . However, fast and slow BDNF perfusion resulted in transient and sustained activation of both TrkB and Erk, respectively (Fig. 5a) . The difference in the signaling kinetics led to markedly different biological effects (Fig. 5d) . Notably, only a slow rate of BDNF delivery facilitated LTP in neonatal hippocampal slices (Fig. 6e,f) . Taken together, these results provide new insights into a controversial issue that bears profound implications.
Our findings may also be relevant to pharmacological treatments using growth factors, and chemical drugs in general. In chemotherapy, for example, continuous, slow intravenous infusion of drugs over 24 h per d has been increasingly favored over the standard, 'bullet' method (a single shot) of drug administration. The general reason is that the bullet administration results in a surge of plasma drug levels that may be toxic and intolerable to patients, and yet the drug concentration in the body quickly reduces to non-effective level because of drug degradation and/or body's drug clearance capacity. Continuous infusion, on the other hand, reduces drug toxicity by eliminating the surge while maintaining a constant drug level in the system for a long period of time. We speculate that the bullet administration and continuous infusion of drugs are analogous to the acute and a r t I C l e S gradual modes of BDNF actions described here. The latter may lead to sustained activation of signal transduction events, which in turn may induce very different patterns of gene expression in the target cells. It is tempting to hypothesize that continuous infusion induces additional or different cellular responses, which may contribute to its superior effects over bullet administration. Further work is necessary to test this hypothesis.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
